The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - VBI Vaccines
Leadership - VBI Vaccines
Stock and Other Ownership Interests - VBI Vaccines
Patents, Royalties, Other Intellectual Property - VBI Vaccines
Interim results of a phase I/IIa trial of a therapeutic CMV vaccine against recurrent glioblastoma (GBM).
 
Andrew B. Lassman
Honoraria - Abbvie; WebMD
Consulting or Advisory Role - Abbvie; Agios; BioClinica; Celgene; Cortice; Kadmon; Karyopharm Therapeutics; Northwest Biotherapeutics; Orbus Therapeutics; Sapience Therapeutics
Research Funding - Abbvie (Inst); Aeterna Zentaris (Inst); Amgen (Inst); BeiGene (Inst); Celldex (Inst); Genentech/Roche (Inst); Kadmon (Inst); Karyopharm Therapeutics (Inst); Millennium (Inst); Novartis (Inst); Oncoceutics (Inst); Pfizer (Inst); VBI Vaccines (Inst)
Travel, Accommodations, Expenses - Agios; Karyopharm Therapeutics; Novocure
 
David A. Reardon
Honoraria - Abbvie; Advantagene; Agenus; Bristol-Myers Squibb; Bristol-Myers Squibb; Cavion; Celldex; EMD Serono; Genentech/Roche; Inovio Pharmaceuticals; Juno Therapeutics; Merck; Merck; Merck KGaA; Midatech Pharma; Momenta Pharmaceuticals; Monteris Medical; Novartis; Novocure; Oncorus; Oxigene; Regeneron; Stemline Therapeutics; Taiho Pharmaceutical
Consulting or Advisory Role - Abbvie; Agenus; Bristol-Myers Squibb; Cavion; Celldex; EMD Serono; Genentech/Roche; Inovio Pharmaceuticals; Juno Therapeutics; Merck; Merck; Merck KGaA; Midatech Pharma; Momenta Pharmaceuticals; Monteris Medical; Novartis; Novocure; Oncorus; Oxigene; Regeneron; Stemline Therapeutics; Taiho Pharmaceutical
Research Funding - Acerta Pharma (Inst); Agenus (Inst); Celldex (Inst); EMD Serono (Inst); Incyte (Inst); Inovio Pharmaceuticals (Inst); Midatech Pharma (Inst); Omniox; Tragara (Inst)
 
Eudocia Quant Lee
Honoraria - Medlink; UpToDate
Consulting or Advisory Role - Lilly
 
Fabio Massaiti Iwamoto
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Merck; Novocure; Regeneron
Speakers' Bureau - Prime Oncology
 
Francisco Diaz-Mitoma
No Relationships to Disclose
 
David E Anderson
Employment - VBI Vaccines
Leadership - VBI Vaccines
Stock and Other Ownership Interests - VBI Vaccines
Patents, Royalties, Other Intellectual Property - VBI Vaccines
 
Patrick Y. Wen
Consulting or Advisory Role - AbbVie; Agios; AstraZeneca; Deciphera; Genentech/Roche; GW Pharmaceuticals; Immunomic Therapeutics; KIYATEC; Lilly; Puma Biotechnology; Taiho Pharmaceutical; Tocagen; Vascular Biogenics; VBI Vaccines; ZIOPHARM Oncology
Speakers' Bureau - Merck; Prime Oncology
Research Funding - Abbvie (Inst); Agios (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Beigene (Inst); Genentech/Roche (Inst); Kazia Therapeutics (Inst); Lilly (Inst); MediciNova (Inst); Merck (Inst); Novartis (Inst); Oncoceutics (Inst); Vascular Biogenics (Inst); Vascular Biogenics (Inst); VBI Vaccines (Inst)